Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÃÊÀ½ÆÄ ¶Ç´Â ÀÚ±â°ø¸í¿µ»ó À¯µµÇÏ¿¡ µû¸¥ Àü¸³¼± Àç°ËÀÇ ¾ÏÁø´ÜÀ² ºñ±³: ¼ºÇâ Á¡¼ö ¸ÅĪ, ´ÜÀÏ º´¿ø °æÇè Serial Comparison of Cancer Detection Rate Between Transrectal Ultrasound Sonography Guided Biopsy and Magnetic Resonance Imaging for Repeat Biopsy by a Propensity Score Matching Cohort: A Single Center Experience

Journal of Urologic Oncology 2019³â 17±Ç 1È£ p.60 ~ 65
¹æ¼®È¯, ÃÖ¿µÈ¿, °­¹Î¿ë, ÀüȲ±Õ, Á¤º´Ã¢, ¼­¼ºÀÏ, Àü¼¼Çö, ±èÂù±³, ¹Úº´°ü, ÀÌÇö¹«,
¼Ò¼Ó »ó¼¼Á¤º¸
¹æ¼®È¯ ( Bang Seok-Hwan ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ºñ´¢ÀÇÇаú

ÃÖ¿µÈ¿ ( Choi Young-Hyo ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼ººó¼¾Æ®º´¿ø ºñ´¢ÀÇÇаú
°­¹Î¿ë ( Kang Min-Yong ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ºñ´¢ÀÇÇаú
ÀüȲ±Õ ( Jeon Hwang-Gyun ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ºñ´¢ÀÇÇаú
Á¤º´Ã¢ ( Jeong Byong-Chang ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ºñ´¢ÀÇÇаú
¼­¼ºÀÏ ( Seo Seong-Il ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ºñ´¢ÀÇÇаú
Àü¼¼Çö ( Jeon Se-Hyun ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ºñ´¢ÀÇÇаú
±èÂù±³ ( Kim Chan-Kyo ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ¿µ»óÀÇÇаú
¹Úº´°ü ( Park Byung-Kwan ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ¿µ»óÀÇÇаú
ÀÌÇö¹« ( Lee Hyun-Moo ) 
¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ºñ´¢ÀÇÇаú

Abstract


Purpose: To compare biopsy performance of 2 approaches for multiparametric magnetic resonance imaging (MRI) guided biopsy and transrectal ultrasonography (TRUS)-guided biopsy with 2nd and 3rd repeat biopsy patients in prostate cancer detection.

Materials and Methods: This retrospective study reviewed 2,868 patients who was performed prostate biopsy between September 2013 to March 2017 at Samsung Medical Center, Seoul, Korea with TRUS-guided random biopsy and MRI fusion, MRI cognitive, and MRI-guided biopsy as 2nd and 3rd repeat biopsy and propensity matching was applied to reduce bias. Detection rate of each study was compared with 1:1 matching.

Results: Among 265 patients who performed TRUS 2nd biopsy, positivity rate for prostate cancer (PCa) was 18.49% (n=49/265) while 54.72% (n=145/265) for MRI-guided biopsy. In 3rd biopsy, positivity rate for PCa of TRUS biopsy was 17.74% (n=11/62) while 56.45% (n=35/62) for MRI guided biopsy. There was no significant difference in the detection rate for the patient with Gleason score 8 or more.

Conclusions: MRI-guided biopsy was associated with a higher detection rate of prostate cancer with especially in patients with prior negative biopsy.

Å°¿öµå

Prostatic neoplasm; Repeat biopsy; Magnetic resonance imaging; Transrectal ultrasonography; Outcome

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI